HomeCompareJOBS vs ABBV

JOBS vs ABBV: Dividend Comparison 2026

JOBS yields 3.28% · ABBV yields 3.09%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ABBV wins by $79.0K in total portfolio value
10 years
JOBS
JOBS
● Live price
3.28%
Share price
$60.90
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.7K
Annual income
$405.71
Full JOBS calculator →
ABBV
AbbVie Inc.
● Live price
3.09%
Share price
$214.96
Annual div
$6.65
5Y div CAGR
40.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$103.7K
Annual income
$25,324.79
Full ABBV calculator →

Portfolio growth — JOBS vs ABBV

📍 ABBV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodJOBSABBV
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, JOBS + ABBV cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
JOBS pays
ABBV pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

JOBS
Annual income on $10K today (after 15% tax)
$279.15/yr
After 10yr DRIP, annual income (after tax)
$344.85/yr
ABBV
Annual income on $10K today (after 15% tax)
$262.96/yr
After 10yr DRIP, annual income (after tax)
$21,526.07/yr
At 15% tax rate, ABBV beats the other by $21,181.22/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of JOBS + ABBV for your $10,000?

JOBS: 50%ABBV: 50%
100% ABBV50/50100% JOBS
Portfolio after 10yr
$64.2K
Annual income
$12,865.25/yr
Blended yield
20.04%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ABBV right now

JOBS
Analyst Ratings
5
Hold
Consensus: Hold
ABBV
Analyst Ratings
27
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$256.15
+19.2% upside vs current
Range: $223.00 — $299.00
Altman Z
2.0
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

JOBS buys
0
ABBV buys
7
PoliticianChamberTickerTypeAmountDate
Julie Johnson🏢 House$ABBV▼ Sell$1,001 - $15,0002025-12-18
Julia Letlow🏢 House$ABBV▼ Sell$1,001 - $15,0002025-12-08
Julie Johnson🏢 House$ABBV▼ Sell$1,001 - $15,0002025-11-13
Lisa McClain🏢 House$ABBV▼ Sell$1,001 - $15,0002025-10-31
Lisa McClain🏢 House$ABBV▼ Sell$1,001 - $15,0002025-10-30
Lisa McClain🏢 House$ABBV▲ Buy$1,001 - $15,0002025-10-30
John Boozman🏛 Senate$ABBV▼ Sell$1,001 - $15,0002025-08-22
John Boozman🏛 Senate$ABBV▼ Sell$1,001 - $15,0002025-08-22
Julie Johnson🏢 House$ABBV▼ Sell$1,001 - $15,0002025-08-14
John Boozman🏛 Senate$ABBV▼ Sell$1,001 - $15,0002025-08-11
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricJOBSABBV
Forward yield3.28%3.09%
Annual dividend / share$2.00$6.65
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.6%
Portfolio after 10y$24.7K$103.7K
Annual income after 10y$405.71$25,324.79
Total dividends collected$3.7K$62.2K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: JOBS vs ABBV ($10,000, DRIP)

YearJOBS PortfolioJOBS Income/yrABBV PortfolioABBV Income/yrGap
1← crossover$11,028$328.41$11,555$434.96$527.00ABBV
2$12,139$338.49$13,485$635.47$1.3KABBV
3$13,337$348.20$15,933$937.67$2.6KABBV
4$14,628$357.53$19,118$1,400.80$4.5KABBV
5$16,018$366.49$23,384$2,125.24$7.4KABBV
6$17,515$375.07$29,290$3,286.81$11.8KABBV
7$19,124$383.28$37,776$5,205.38$18.7KABBV
8$20,854$391.12$50,495$8,488.44$29.6KABBV
9$22,712$398.59$70,497$14,346.44$47.8KABBV
10$24,708$405.71$103,718$25,324.79$79.0KABBV

JOBS vs ABBV: Complete Analysis 2026

JOBSStock

51job, Inc., through its subsidiaries, provides integrated human resource services in the People's Republic of China. The company offers online recruitment services through its Websites comprising 51job.com, yingjiesheng.com, 51jingying.com, lagou.com, and 51mdd.com; and mobile applications that enable job seekers to access their accounts through mobile devices and utilize functions available on their Websites. It also provides other human resource related services, such as business process outsourcing that consist of social insurance, benefits, and payroll processing, as well as compliance services with local governmental employment regulations; and conducts training seminars in the business management, leadership, sales and marketing, human resource, negotiation skills, financial planning and analysis, public administration, manufacturing, secretarial, and other skills. In addition, the company offers campus recruitment services to corporations that seek to recruit college and university students; and placement and executive search services to employers seeking to attract talent and fill job vacancies. Further, it provides professional and scientific assessment tools that assist human resource departments in evaluating capabilities and dispositions of job candidates and existing employees, as well as offers talent assessment services; conducts general and customized surveys on salary, employee retention, and other human resource related topics; organizes and hosts annual human resource conferences and events; and provides support and administrative services to employers on select recruitment projects. The company serves multinational corporations, large national Chinese corporations, and the local Chinese enterprises. It offers its services through sales offices, and a national sales and customer service call center in Wuhan. 51job, Inc. was founded in 1998 and is headquartered in Shanghai, the People's Republic of China.

Full JOBS Calculator →

ABBVHealthcare

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Full ABBV Calculator →
📬

Get this JOBS vs ABBV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

JOBS vs SCHDJOBS vs JEPIJOBS vs OJOBS vs KOJOBS vs MAINJOBS vs JNJJOBS vs MRKJOBS vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.